Institutional Ownership
Vor Biopharma Inc
CUSIP 929033207COM NEWVORQ1 2026
13D / 13G Filings
22
Schedule 13D/13G on record
Beneficial Filers
11
Distinct reporting persons
Largest Stake
29.0%
Max % of class reported
Institutional Holders
77
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
22 filings · latest Feb 17, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 17, 2026 | Verve Capital Limited | 13G/A | 9.9% | 4.30M | SEC |
| 2 | Feb 17, 2026 | Venrock Healthcare Capital Partners III, L.P. | 13G/A | 9.9% | 2.22M | SEC |
| 3 | Feb 17, 2026 | Great Point Partners, LLC | 13G/A | 3.3% | 1.37M | SEC |
| 4 | Feb 17, 2026 | Paradigm Biocapital Advisors LP | 13G/A | 4.5% | 9.23B | SEC |
| 5 | Feb 13, 2026 | Qiming Venture Partners Viii-Hc, L.P. | 13G/A | 2.8% | 1.09M | SEC |
| 6 | Feb 5, 2026 | Fmr LLC | 13G/A | 6.5% | 2.53M | SEC |
| 7 | Dec 23, 2025 | Forgrowth III Pa B.V. | 13D | 10.0% | — | SEC |
| 8 | Dec 19, 2025 | Frazier Life Sciences Public Fund, L.P. | 13G | 5.8% | 2.26M | SEC |
| 9 | Dec 18, 2025 | Ra Capital Management, L.P. | 13D/A | 14.0% | — | SEC |
| 10 | Dec 17, 2025 | Great Point Partners, LLC | 13G | 5.6% | 1.23M | SEC |
12 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Vor Biopharma Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Tcg Crossover Management, LLC | 5.67M | $96.50M |
| 2 | Ra Capital Management, L.P. | 5.40M | $96.43M |
| 3 | Fcpm III Services B.V. | 4.12M | $73.45M |
| 4 | Venrock Adviser, LLC | 3.04M | $54.26M |
| 5 | Frazier Life Sciences Management, L.P. | 2.54M | $45.38M |
| 6 | Caligan Partners LP | 1.93M | $34.34M |
| 7 | Great Point Partners LLC | 1.75M | $31.22M |
| 8 | Paradigm Biocapital Advisors LP | 1.75M | $31.22M |
| 9 | Fmr LLC | 1.54M | $27.47M |
| 10 | Marshall Wace, LLP | 1.15M | $20.57M |